Reading the internal control: what RNase P tells you

Method & sample types

The Healthincode SARS CoV 2 RNaseP Kit co-amplifies the SARS-CoV-2 target alongside human RNase P (gene RPP30), a human housekeeping gene present in any adequately collected respiratory swab. Because RNase P amplifies from human cellular material rather than from the pathogen itself, its signal is a direct read on sample adequacy and extraction/amplification performance, not just a generic reagent control.

Controls & interpretation

A valid negative result requires the RNase P channel to amplify: if it does, a negative SARS-CoV-2 channel can be reported with confidence that the sample actually contained human material and that extraction and amplification worked. If RNase P fails to amplify, the run is invalid regardless of the SARS-CoV-2 result, this most often reflects a poorly collected swab (too little cellular material), extraction failure, or PCR inhibition, and the correct action is to request a repeat sample or repeat the extraction, not to report the SARS-CoV-2 channel as a true negative.

Workflow integration

Building the adequacy check into the same reaction as the pathogen target, rather than as a separate process control, means every single sample gets its own individual adequacy read, not just a batch-level control. For high-volume testing, this materially reduces false-negative risk from poor swab technique without adding a separate assay or well to the workflow.